Team:Paris/Modeling/Protocol Of Characterization

From 2008.igem.org

(Difference between revisions)
(IV-Resulting plasmids)
(VI-B-Accessory plasmid construction)
 
(43 intermediate revisions not shown)
Line 6: Line 6:
== I-Principles of the Experiments ==
== I-Principles of the Experiments ==
-
To evaluate quantitativly the activity of a promoter in function of its transcription factors, we need data in which the different values of the activities are correlated with various ''known'' and ''controlled'' values of the transcription factors concentrations. Therefore, we designed a generic plasmid in which the transcription factors are put under the control of ''previously characterized inducible promoter'', and the studied promoter is put before a fluorescent reporter gene. In order to allow the study of the influence of two transcription factors over the tested pormoter, we chose to put the tested genes  under two different inducible systems . One is the pBAD-AraC system. The second one is an indirect system were the gene is after the Tet inducible promoter « pTet ». The TetR gene would be expressed constitutively and at high rate thanks to a strong promoter (J23101) and its influence over the pTet promoter would be regulated by the concentration of the aTc molecule. That way the production of the tested gene can also be regulated.  The J23101 and the pTet have been previously characterized.
+
To evaluate quantitativly the activity of a promoter in function of its transcription factors, '''we need data in which the different values of the activities are correlated with various ''known'' and ''controlled'' values of the transcription factors concentrations'''. <br><br>
 +
Therefore, we designed a generic plasmid in which the transcription factors are put under the control of ''previously characterized inducible promoter'', and the studied promoter is put before a fluorescent reporter gene. In order to allow the study of the influence of two transcription factors over the tested pormoter, we chose to put the tested transcription factor (also called the "tested gene" in the following) under two different inducible systems . One is the ''pBAD-AraC'' system. The second one is an indirect system were the gene is after the Tet inducible promoter ''pTet''. <br><br>
 +
The ''TetR'' gene would be expressed constitutively and at high rate thanks to a strong promoter (''J23101'') and its influence over the ''pTet'' promoter would be regulated by the concentration of the aTc molecule. That way, the production of the tested transcription factor can also be regulated, because the ''J23101'', and the ''pTet'' have been previously characterized. In a quite similar way, we characterize the ''pBad'' promoter.<br><br>
Here we show the design of two plasmids : one to test the influence of one gene and the other to test the influence of two genes over the tested promoter.
Here we show the design of two plasmids : one to test the influence of one gene and the other to test the influence of two genes over the tested promoter.
Line 13: Line 15:
[[Image:I-A-PCP.png|900px|The main design.]]
[[Image:I-A-PCP.png|900px|The main design.]]
-
 
===II-B-For study with two Transcription Factor===
===II-B-For study with two Transcription Factor===
Line 21: Line 22:
==III-Molecular design for Promoter Characterization Plasmid==
==III-Molecular design for Promoter Characterization Plasmid==
-
Our aim is to make this plasmid useful not only for our project but for the whole iGEM comunity. This is why we decided to keep the Biobrick spirit as much as we could, making the plasmid compatible with the parts, so the teams using it need only the four traditional enzymes: EcoRI, XbaI, SpeI and PstI.We wanted also to make optional the introduction of a second tested gene.  The strategy is then based in two plasmids. The principal plasmid contains everything needed to test the effect of one gene over the tested promoter activity. The second plasmid called « Accessory plasmid » can be introduced easily in the Principal Plasmid and contains the necessary elements to add the expression of a second gene to the system. The resulting plasmids are presented below.   
+
Our aim is to make this plasmid useful not only for our project but for the whole iGEM comunity. This is why we decided to keep the Biobrick spirit as much as we could, making the plasmid compatible with the parts, so the teams using it needs only the four traditional enzymes: EcoRI, XbaI, SpeI and PstI.We wanted also to make optional the introduction of a second tested transcription factor.  The strategy is then based in two plasmids. <br><br>
 +
The principal plasmid contains everything needed to test the effect of one gene over the tested promoter activity. The second plasmid called « Accessory plasmid » can be introduced easily in the Principal Plasmid and contains the necessary elements to add the expression of a second gene to the system. The resulting plasmids are presented below.   
 +
<div style="text-align: left">
 +
{{Paris/Toggle|'''III-A-Principal plasmid'''|Team:Paris/Modeling/More_Principal_Plasmid|900px}}
 +
</div>
-
===III-A-Principal plasmid===
 
-
[[Image:II-A-PCP.png|900px|The main design.]]
 
-
 
+
<div style="text-align: left">
-
===III-B-Accessory plasmid===
+
{{Paris/Toggle|'''III-B-Accessory plasmid'''|Team:Paris/Modeling/More_Accessory_Plasmid|600px}}
-
 
+
</div>
-
[[Image:II-B-PCP.png|900px|The main design.]]
+
==IV-Promoter and Transcription Factors insertion==
==IV-Promoter and Transcription Factors insertion==
-
The strategy to introduce the tested promoter and the tested gene(s) is very simple. The only difficulty is that the order of insertion that we describe has to be respected to avoid unwanted restriction enzyme cuts:
+
The strategy to introduce the tested promoter and the tested transcription factor(s) is very simple. The only difficulty is that the order of insertion that we describe has to be respected to avoid unwanted restriction enzyme cuts:
-
*1st step: Introduce the tested promoter:
+
<div style="text-align: center">
-
-Cut Promoter with EcoRI and SpeI
+
{{Paris/Toggle|'''The Steps'''|Team:Paris/Modeling/More_The_Steps|700px}}
-
-Cut Principal plasmid with EcoRI and XbaI
+
</div>
-
*2nd step: Introduce the 1st tested gene:
+
-
-Cut Gene with XbaI and SpeI
+
-
-Cut Principal plasmid+Promoter with SpeI
+
-
-Check the right orientation of the 1st gene by PCR with appropiated primers
+
-
If wanted…
 
-
*3rd step: Introduce the 2nd gene into the Accessory plasmid
+
<div style="text-align: center">
-
-Cut Gene with XbaI and SpeI
+
{{Paris/Toggle|'''Illustration'''|Team:Paris/Modeling/More_Illustration_Steps|900px}}
-
-Cut Accessory Plasmid with XbaI and SpeI
+
</div>
-
-Check the right orientation of the 2nd gene by PCR with appropiated primers4
+
-
*4th step: Introduce the 2nd gene expression system into the Principal Plasmid:
+
-
-Cut Accessory Plasmid+2nd gene with PstI
+
-
-Cut Principal plasmid+Promoter+1st gene with SpeI
+
-
-Check the right orientation of the 2nd gene expression system by PCR with appropiated primers 
+
-
 
+
-
 
+
-
[[Image:III-PCP.png|900px|The main design.]]
+
==V-Resulting plasmids==
==V-Resulting plasmids==
Line 70: Line 59:
[[Image:IV-B-PCP.png|900px|The main design.]]
[[Image:IV-B-PCP.png|900px|The main design.]]
-
==V-Protocole for plasmid construction==
+
==VI-Protocole for plasmid construction==
We show here our plan to make these plasmids at the experimental level.
We show here our plan to make these plasmids at the experimental level.
-
===V-A-Principal Plasmid construction===
+
===VI-A-Principal Plasmid construction===
We devided the Principal Plasmid in two main blocks to go faster:
We devided the Principal Plasmid in two main blocks to go faster:
-
====V-A-1-Blocks====
+
====VI-A-1-Blocks====
[[Image:V-A-1-PCP.png|900px|The main design.]]
[[Image:V-A-1-PCP.png|900px|The main design.]]
-
====V-A-2-Block 1 construction====
+
<div style="text-align: left">
 +
{{Paris/Toggle|'''VI-A-2-Block 1 construction'''|Team:Paris/Modeling/More_Block_I|900px}}
 +
</div>
-
[[Image:V-A-2-a-PCP.png|400px|The main design.]]
+
<br>
-
the result...
+
<div style="text-align: left">
 +
{{Paris/Toggle|'''VI-A-3-Block 2 construction'''|Team:Paris/Modeling/More_Block_II|900px}}
 +
</div>
-
[[Image:V-A-2-b-PCP.png|800px|The main design.]]
+
<br>
-
====V-A-3-Block 2 construction====
+
<div style="text-align: left">
 +
{{Paris/Toggle|'''VI-A-4-Two-block assembly'''|Team:Paris/Modeling/More_Blocks_Assembly|900px}}
 +
</div>
-
Biobrick assembly steps:
+
<br><br>
-
[[Image:V-A-3-a-PCP.png|800px|The main design.]]
+
===VI-B-Accessory plasmid construction===
 +
Addition of restriction sites to B0015 by PCR:
-
Restriction sites addition by PCR:
+
<div style="text-align: center">
 +
{{Paris/Toggle|Scheme|Team:Paris/Modeling/More_Scheme1|800px}}
 +
</div>
-
[[Image:V-A-3-b-PCP.png|400px|The main design.]]
+
Addition of restriction sites to ''pBAD-AraC'' by PCR:
-
====V-A-4-Two-block assembly====
+
<div style="text-align: center">
 +
{{Paris/Toggle|Scheme|Team:Paris/Modeling/More_Scheme2|800px}}
 +
</div>
 +
Assembly:
-
[[Image:V-A-4-PCP.png|800px|The main design.]]
+
<div style="text-align: center">
 +
{{Paris/Toggle|Scheme|Team:Paris/Modeling/More_Scheme3|800px}}
 +
</div>
-
===V-B-Accessory plasmid construction===
+
== Specific Assumptions for the Experiments ==
-
Addition of restriction sites to B0015 by PCR:
+
The previous experiment is used to find parameters regarding to our modelization. However, the experiments themselves must be described in the same way to interprete these parameters consistently.
-
[[Image:V-B-1-PCP.png|800px|The main design.]]
+
In this order, the two inductible promoters will be described exactly as the others (those in the system), with similar rules of complexation and transcription.
-
Addition of restriction sites to pBAD-AraC by PCR:
+
Otherwise, as we control the quantity of transcription factor by the introduction of small molecules, we must model the diffusion/complexation/induction phenomena, which lead from the latter to the former.  By putting the cell culture in a chemostat, we will be able to control precisely the concentration of the input small molecules. At ''quasi steady-state'', and assuming a ''simple, passive and quick diffusion'', we consider the '''inner concentration''', the '''outer medium concentration''', and the '''input concentration''' beeing all '''equal'''.
-
[[Image:V-B-2-PCP.png|800px|The main design.]]
+
<div style="text-align: center">
 +
{{Paris/Toggle|Quick Mathematical Development|Team:Paris/Modeling/More_Math_Dvlp|700px}}
 +
</div>
-
Assembly:
+
Thanks to these considerations, we can have access to these characterizations :
 +
 
 +
<div style="text-align: center">
 +
{{Paris/Toggle|Prior characterizations|Team:Paris/Modeling/More_Algo_Prior|300px}}
 +
</div>
-
[[Image:V-B-3-PCP.png|800px|The main design.]]
+
and then
-
== Assumptions Specific to the Experiments ==
+
<div style="text-align: center">
 +
{{Paris/Toggle|System characterizations|Team:Paris/Modeling/More_Algo_Finder|300px}}
 +
</div>
-
The previous experiment is used to find parameters regarding to our modelization. However, the experiments themselves must be described in the same way to involve those parameters in a consistent way, and actually, to be interpreted.
+
<div style="text-align: center">
 +
It is important to follow the previous chronological order for the successive characterizations, because some results are reused in the next !
 +
</div>
<br>
<br>

Latest revision as of 03:06, 30 October 2008

Protocol of Characterization



Contents

I-Principles of the Experiments

To evaluate quantitativly the activity of a promoter in function of its transcription factors, we need data in which the different values of the activities are correlated with various known and controlled values of the transcription factors concentrations.

Therefore, we designed a generic plasmid in which the transcription factors are put under the control of previously characterized inducible promoter, and the studied promoter is put before a fluorescent reporter gene. In order to allow the study of the influence of two transcription factors over the tested pormoter, we chose to put the tested transcription factor (also called the "tested gene" in the following) under two different inducible systems . One is the pBAD-AraC system. The second one is an indirect system were the gene is after the Tet inducible promoter pTet.

The TetR gene would be expressed constitutively and at high rate thanks to a strong promoter (J23101) and its influence over the pTet promoter would be regulated by the concentration of the aTc molecule. That way, the production of the tested transcription factor can also be regulated, because the J23101, and the pTet have been previously characterized. In a quite similar way, we characterize the pBad promoter.

Here we show the design of two plasmids : one to test the influence of one gene and the other to test the influence of two genes over the tested promoter.

II-Plasmid for promoter characterization

II-A-For study with one Transcription Factor

The main design.

II-B-For study with two Transcription Factor

The main design.

III-Molecular design for Promoter Characterization Plasmid

Our aim is to make this plasmid useful not only for our project but for the whole iGEM comunity. This is why we decided to keep the Biobrick spirit as much as we could, making the plasmid compatible with the parts, so the teams using it needs only the four traditional enzymes: EcoRI, XbaI, SpeI and PstI.We wanted also to make optional the introduction of a second tested transcription factor. The strategy is then based in two plasmids.

The principal plasmid contains everything needed to test the effect of one gene over the tested promoter activity. The second plasmid called « Accessory plasmid » can be introduced easily in the Principal Plasmid and contains the necessary elements to add the expression of a second gene to the system. The resulting plasmids are presented below.

III-A-Principal plasmid


The main design


III-B-Accessory plasmid


The main design

IV-Promoter and Transcription Factors insertion

The strategy to introduce the tested promoter and the tested transcription factor(s) is very simple. The only difficulty is that the order of insertion that we describe has to be respected to avoid unwanted restriction enzyme cuts:

The Steps


  • 1st step: Introduce the tested promoter:

-Cut Promoter with EcoRI and SpeI -Cut Principal plasmid with EcoRI and XbaI

  • 2nd step: Introduce the 1st tested transcription factor:

-Cut Gene with XbaI and SpeI -Cut Principal plasmid+Promoter with SpeI -Check the right orientation of the 1st gene by PCR with appropiated primers

If wanted…

  • 3rd step: Introduce the 2nd gene into the Accessory plasmid

-Cut Gene with XbaI and SpeI -Cut Accessory Plasmid with XbaI and SpeI -Check the right orientation of the 2nd gene by PCR with appropiated primers4

  • 4th step: Introduce the 2nd gene expression system into the Principal Plasmid:

-Cut Accessory Plasmid+2nd gene with PstI -Cut Principal plasmid+Promoter+1st gene with SpeI -Check the right orientation of the 2nd gene expression system by PCR with appropiated primers


Illustration


The main design.

V-Resulting plasmids

V-A-For one transcription factor effect

The main design.


V-B-For two transcription factors effect

The main design.

VI-Protocole for plasmid construction

We show here our plan to make these plasmids at the experimental level.

VI-A-Principal Plasmid construction

We devided the Principal Plasmid in two main blocks to go faster:

VI-A-1-Blocks

The main design.

VI-A-2-Block 1 construction


The main design

the result...

The main design


VI-A-3-Block 2 construction


Biobrick assembly steps:

The main design


Restriction sites addition by PCR:

The main design


VI-A-4-Two-block assembly


The main design



VI-B-Accessory plasmid construction

Addition of restriction sites to B0015 by PCR:

↓ Scheme ↑


The main design

Addition of restriction sites to pBAD-AraC by PCR:

↓ Scheme ↑


The main design

Assembly:

↓ Scheme ↑


The main design

Specific Assumptions for the Experiments

The previous experiment is used to find parameters regarding to our modelization. However, the experiments themselves must be described in the same way to interprete these parameters consistently.

In this order, the two inductible promoters will be described exactly as the others (those in the system), with similar rules of complexation and transcription.

Otherwise, as we control the quantity of transcription factor by the introduction of small molecules, we must model the diffusion/complexation/induction phenomena, which lead from the latter to the former. By putting the cell culture in a chemostat, we will be able to control precisely the concentration of the input small molecules. At quasi steady-state, and assuming a simple, passive and quick diffusion, we consider the inner concentration, the outer medium concentration, and the input concentration beeing all equal.

↓ Quick Mathematical Development ↑


Thus, if we consider these "rules"

Rulescompldiff.jpg

it gives at quasi steady-state

Qssdiff.jpg

resulting in the following analytical expression of [Compl] and [Prot] :

Concfinaldiff.jpg

...that we can introduce in the expression of the activity of pTet and pBad in function of their transcription factor.

Thanks to these considerations, we can have access to these characterizations :

and then

It is important to follow the previous chronological order for the successive characterizations, because some results are reused in the next !


<Back to "Workflow on an Example"|